LIMK1 and breast carcinoma: Moreover, miR-128-3p could participate in the progression of diver cancers through targeting different genes, and miR-128-3p regulated cell growth in breast cancer by targeting LIMK1 and overexpression of miR-128-3p in breast cancer patients presaged a good prognosis [11].